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Abstract
Limited proteolysis, accomplished by endopeptidases, is a ubiquitous phenomenon underlying the
regulation and activation of many enzymes, receptors and other proteins synthesized as inactive
precursors. Serine proteases are one of the largest and conserved families of endopeptidases
involved in diverse cellular activities including wound healing, blood coagulation and immune
responses. Heteromeric α,β,γ-epithelial sodium channels (ENaC) associated with diseases like
cystic fibrosis and Liddle’s syndrome, are irreversibly stimulated by membrane-anchored
proteases (MAPs) and furin-like convertases. Matriptase/Channel activating protease-3 (CAP3) is
one of the several MAPs that potently activate ENaC. Despite identification of protease cleavage
sites, the basis for enhanced susceptibility of α- and γ-ENaC to proteases remains elusive. Here,
we elucidate the energetic and structural bases for activation of ENaC by CAP3. We find a region
near the γ-ENaC furin site that is previously unidentified as a critical cleavage site for CAP3-
mediated stimulation. We also report that CAP3 mediates cleavage of ENaC at basic residues
downstream of the furin site. Our results indicate that surface proteases alone are sufficient to fully
activate uncleaved ENaC, and explain how ENaC in epithelia expressing surface-active proteases
can appear refractory to soluble proteases. Our results support a model in which proteases prime
ENaC for activation by cleaving at the furin site, and cleavage at downstream sites is
accomplished by membrane surface proteases or extracellular soluble proteases. Based on our
results, we propose a dynamics-driven “anglerfish” mechanism that explains less stringent
sequence requirements for substrate recognition and cleavage by matriptase compared to furin.
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Limited proteolysis is the last step in the attainment of a functional form of many proteins of
biological significance and perhaps the first step in protein degradation (1). This important
regulatory phenomenon is frequently observed in activation of many enzymes, hormones,
receptors, and other biologically active proteins and is conserved through evolution (2).
Early structural studies on limited proteolysis led to two opposing theories that argued
whether it is segmental mobility or surface accessibility of the proteolytic fragment that
determines protease susceptibility (3, 4). Following these hypotheses, others have performed
systematic computational analyses concluding that local unfolding, in addition to segmental
mobility and surface accessibility, guides protease susceptibility (5, 6). Although the
structural requirements for cleavage by serine proteases are relatively well characterized (7),
the energetics of enzyme-substrate interactions remains unclear. Determining the energetics
of enzyme-substrate interactions is critical to understand the subtle differences in substrate
specificities featured by serine proteases. The ENaC family of ion channels offers a unique
platform to study limited proteolysis due to the uniqueness of the mode of their regulation
via cleavage by proteases, resulting in constitutive channel activation.
ENaC is considered the rate-limiting step in electrogenic Na+ absorption from luminal
compartments lined by epithelia. Na+ absorption by ENaC is critical in many biological
processes including renal and intestinal control of salt balance and blood pressure and
affects the functioning of many organs including airways, sweat ducts, cornea and inner ear
(8–11). Over the last decade it has become clear that an important determinant of ENaC
activity is the extent of partial proteolysis of the channel subunits (12, 13). Proteolytic
regulation of ENaC includes selective cleavage by furin-like proteases during biosynthetic
maturation as well as cleavage at the cell surface by proteases that can be membrane-
associated or soluble. The current model for proteolytic regulation of ENaC is that the open
probability (PO) of the heteromultimer is determined by cleavage events, so far confined to
its α and γ subunits. In general, channels made of uncleaved subunits exhibit a very low PO
and a range of cleavage events increases PO. Two specific gaps in understanding proteolytic
activation of ENaC involve the dominant role of γ-ENaC in proteolytic regulation of the
channel. First, studies of at least five ENaC activating proteases identify essential sites in γ-
ENaC, despite accepted importance of furin-like cleavage sites in α-ENaC. Second, the
structural and/or energetic features of the region of γ-ENaC (residues 130–200), that renders
it susceptible to cleavage by multiple proteases, have not been investigated.
Previous studies on MAPs including prostasin/CAP1 and TMPRSS4/CAP2 revealed an
important role for γ-ENaC in channel regulation via limited proteolysis (14–16).
Additionally, the extracellular domain of γ-ENaC has been hypothesized to harbor an
allosteric regulatory subdomain with an important role in channel function (17).
Interestingly, proteolytic activity of CAP1 is not required for its stimulation of ENaC. This
observation led to a suggestion that CAP1 may play a critical non-catalytic role in ENaC
regulation, perhaps as part of a cascade of surface associated proteases (18). It was recently
demonstrated that matriptase/CAP3 is a critical activator of CAP1 (19). In this study we
focus on the activation of rat ENaC by CAP3-mediated cleavage of the γ subunit.
To uncover the energetic basis for activation of ENaC upon cleavage, we performed
computational analyses on peptides from ENaC that are susceptible to proteolysis by serine
proteases. We performed discrete molecular dynamics (DMD) simulations to elucidate the
structural and energetic bases for ENaC peptide recognition by CAP3. Our computational
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studies of various peptide-binding configurations to CAP3 establish the structural and
energetic bases for CAP3 activity. Using potential of mean force (PMF) analyses, we
determined the energetic basis for substrate recognition and cleavage by CAP3. We
compared the results to those obtained via similar analyses for furin and elucidate the
energetic basis for the lower sequence specificity of CAP3 compared to furin. We designed
experimental studies to identify CAP3-mediated cleavage sites in ENaC that lead to channel
activation. We conclude that CAP3, with less stringent sequence requirements than furin,
robustly activates ENaC by cleaving at multiple basic residues in the extracellular domain.
Using computational and experimental studies, we show that a site upstream of the
traditional furin site in γ-ENaC is a potential substrate for CAP3. Based on our findings, we
propose an “anglerfish” mechanism driven by dynamics of the enzyme whereby the peptide
substrate interacts with and is stabilized by the loops enveloping the active site of the
enzyme and is subsequently subject to proteolysis. This two-step mechanism underscores
the importance of the energetic contribution of surface loops in serine proteases to their
proteolytic activity. Furthermore, this mechanism provides a broad outlook for
understanding stringency in sequence requirements for cleavage by serine proteases.
Materials and Methods
Enzyme-peptide Docking
We represented γ-ENaC cleavage sites tentatively identified by mutagenesis by 8-mer
peptides with the putative wild type P4-P1 cleavage sequence contained in the first four
residues. We constructed three linear 8-mer peptides from rat γ-ENaC (Seq1: 135-
RKRREAGS; Seq2: 178-RKRKISGK; Seq3: 132-KESRKRRE) such that the P1 site is
between the fourth and fifth residues. We chose the initial configuration for the peptide by
random placement at sites distant from the active site of either enzyme. We imposed two
distance constraints – one between the epsilon nitrogen atom (NE2) of active site histidine
and backbone amine of the P1’ site on the peptide and the other between the gamma oxygen
atom (OG) of active site serine and carbonyl oxygen of the P1 site – to draw the peptide
close to the active pocket. In order not to bias the configuration of the peptide in the active
site of the enzyme, we placed the peptide at ten different, randomly chosen starting positions
and with different orientations with respect to one another (Figure S2A, B). We performed
replica exchange DMD simulations of each such initial configuration with eight replicas in a
temperature range of 0.35 to 0.75 reduced units at increments of 0.035 units (Figure S2C)
(20). DMD uses Medusa force field to treat interactions between atoms in the
macromolecule (21). We used EEF1, an implicit solvation model to treat the solvation of the
simulation system (22). Energy minimization of the crystal structure of furin and matriptase
was performed using Chiron prior to replica exchange simulations (23). The total simulation
time was 106 DMD time units for each replica. Each DMD time unit is approximately 50 fs
in real time, accounting for a total simulation time of 50 ns per replica. The relationship
between DMD time unit and real time and their inter-conversion is discussed elsewhere
(24). Proteases were maintained static during simulations allowing movement of only the
loops surrounding the active site. We selected snapshots across simulation trajectories of all
replicas that satisfied both the distance constraints and clustered them based on pair wise
root mean square deviation (RMSD) of Cα atoms. We selected the representative structures
from five such clusters and performed side-chain optimization using the fixed backbone
custom design protocol from the Medusa suite (21).
PMF Calculations
To estimate the free energy of peptide binding for each enzyme-peptide combination, we
computed 2D-PMF using distance from the active site and energy as reaction coordinates.
To obtain an accurate estimate of free energy, we removed the bias from the simulation
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trajectories by subtracting the appropriate value of constraint potential as a function of
distance from the active site. We used the multiscale modeling tools for structural biology
(MMTSB) toolkit (25) to perform WHAM (weighted histogram analysis method) analysis
with replica-exchange simulation trajectories and compute PMFs at a given temperature.
Using WHAM analysis, we self-consistently computed the density of states by combining
overlapping histograms from different simulation trajectories (26). We generated 2D-
contour plots of the 2D-PMF values using gnuplot (http://www.gnuplot.info).
Peptide Disorder Prediction
We used Disopred2 (http://bioinf.cs.ucl.ac.uk/disopred) to analyze the peptide sequences of
alpha, beta and gamma subunits of rat ENaC. We used the sequences L150–L290 from rat
α-ENaC, K117-P240 from rat β-ENaC and K91-S222 from rat γ-ENaC.
Plasmid Preparation
For biochemical analyses of ENaC subunit proteolysis, cDNAs encoding rat α,β and γ-
ENaC with HA-N-terminal (HA-NT) and V5-C-terminal (V5-CT) epitope tags were
generated. Wild type and mutant constructs (α-ENaC; R205A/R231A, β-ENaC, γ-ENaC;
R135Q/K136Q/R137Q/R138Q, R135Q/K136Q/R137Q/R138;R135Q/K136Q/R137/
R138Q;R135Q/K136/R137Q/R138Q/R135/K136Q/R137Q/R138Q, hepatocyte growth
factor activator inhibitor 1 and 2 (HAI-1, HAI2) and CAP3 were generated by PCR and
cloned into pCR-BluntII-TOPO (Invitrogen), linearized (HindIII) and in vitro transcribed
using T7 RNA polymerase. A PolyA tail was added after transcription (Ambion). Mutations
were done with the Quikchange multi site-directed mutagenesis kit (Stratagene). The WT
ENaC plasmids were generously provided by Dr. Bernard Rossier. The sequence of all
plasmids was verified at the University of North Carolina sequencing facility.
Western Blot Analysis
Proteins were extracted from oocytes as described above. Biotinylated and total proteins
were solubilized by boiling in Laemmli sample buffer for 10 min prior to loading onto 4–
12% SDS-PAGE gels. Western blots were performed with anti-V5 (Invitrogen), anti-HA
(Covance), anti-CAP3 (Bethyl, Laboratories, Inc.) and anti-actin (Chemicon International)
antibodies.
Functional Studies of ENaC in Xenopus oocytes
V–VI stage healthy oocytes were harvested as described previously (27) and maintained in
modified Barth’s solution (MBS) at 18°C. Animals were maintained and studied under
protocols approved by the University of North Carolina Institutional Animal Care and Use
Committee. Oocytes expressing the desired combinations of ENaC subunits and CAP3 were
obtained as before (14). Briefly, cRNAs encoding wild-type (WT) of both untagged and
HA-NT/V5-CT epitope tagged subunits or mutant HA-NT/V5-CT tagged subunits of rat αβ
and γ-ENaC (0.3 ng each) and CAP3 cRNA (typically 1 ng) were co-injected into oocytes.
Twenty-four hr after injection, two-electrode voltage clamping was performed using a
Genclamp amplifier (Axon Instruments) in a constant perfusion system. Currents were
measured in the presence and absence of 10 µM amiloride, with membrane voltage clamped
to −100 mV. Currents were digitized and recorded using a Digidata 1200 A/D converter
(Axon Instruments) and Axoscope software. After basal amiloride sensitive current (INa)
was recorded by washing out amiloride, oocytes were superfused with amiloride containing
buffer and trypsin or hNE (2–20 µg/ml) for 5 m, followed by a second determination of INa.
All results are expressed as the mean ± S.E. or as fold stimulation by CAP3 or hNE. The
means of two groups were tested for significant difference using an unpaired Student’s t test,
differences between three or more groups were evaluated using ANOVA analysis
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(GraphPad Prism software). Proteins extracted from control and injected oocytes were
analyzed by Western blots to verify expression of ENaC and actin.
Surface labeling
Xenopus oocytes were injected with desired combinations of WT or mutant double epitope
(HA/V5) tagged αβ and γ rat ENaC subunits (0.3 ng each) and with or without CAP3
cRNA (1 ng). After 24 hrs, 70 oocytes per experimental condition were pre-chilled on ice
for 30 minutes and labeled with 0.7 mg/ml sulfo-NHS-biotin in MBS-Ca++ (mM), 85 NaCl,
1 KCl, 2.4 NaHCO3, 0.82 MgSO4, 0.41 CaCl, 0.33 Ca(NO3), 16.3 hepes titrated to pH 8.0
with NaOH, while tumbling gently for 20 min at 4°C. Oocytes were washed twice with
chilled MBS-Ca++ buffer and incubated in MBS-Ca2+ buffer with 100 mM glycine for 10
min at 4°C to quench free biotin. Oocytes were washed again three times with chilled MBS-
Ca++ buffer, then lysed with lysis buffer (in mM; 20 Tris, 50 NaCl, 50 NaF, 10 β-
glycerophosphate, 5 Na4P2O7 pyrophosphate, 1 EDTA, pH 7.5 containing protease
inhibitors (complete, Roche), aprotinin (Sigma)). Cell lysates were prepared by passing
oocytes through a 27G1/2 needle twice and by centrifugation at 3,600 rpm for 10 minutes at
4°C. Supernatants were transferred to new tubes and samples were spun at 14,000 rpm for
20 minutes at 4°C. Supernatants were discarded and pellets were solubilized in
solubilization buffer (in mM; 50 Tris, 100 NaCl, 1% triton X-100, 1% NP-40, 0.2% SDS,
0.1% Na deoxycholate, 20 NaF, 10 Na4P2O7 pyrophosphate, 10 EDTA + protease inhibitor
cocktail, pH 7.5). Total inputs were taken from whole cell samples representing 4% of total
protein. Solubilized proteins were incubated with 100 µl of neutravidin beads (Pierce)
overnight while tumbling at 4°C. Samples were washed twice with (mM) 500 NaCl 50 Tris
pH 7.5 buffer and once with 150 NaCl 50 Tris pH 7.5 buffer. Laemmli buffer was added and
samples were loaded on a 4–12% gradient Tris-glycine gel after incubation for 10 minutes at
96°C. Samples were transferred to 0.45 µm polyvinylidene difluoride (PVDF) membranes
(Millipore) and Western blot analysis was performed using an anti-V5 (Invitrogen), anti-HA
(Covance) and anti-actin (Chemicon International) monoclonal antibodies. Surface ENaC
biotinylated fragments were quantified using the metamorph imaging 4.5 program (Hooker
Microscopy Facility, University of North Carolina). Densitometry of selected bands was
performed, using uninjected oocyte samples as background signal.
Results
CAP3 has less stringent sequence requirement for cleavage than furin
To assess the accessibility of the known protease cleavage tracts of different subunits of
ENaC, we computed residue-wise disorder probability in the respective segments using
Disopred2 (Figure S1) (28). To eliminate any bias in the prediction, we considered segments
(α: V151-L290; β: K117-P240; γ: K91-S222) such that most of the cleavage sites are
enclosed but are not near either end of the segment. Interestingly, the regions susceptible to
cleavage by furin-like convertases in α- and γ-subunits (α: 202-RSSR, 228-RTAR; γ: 135-
RKRR, 178-RKRK) of rat ENaC are intrinsically disordered (Figure S1A, C). The two
peaks in the disorder plot for γ-ENaC correspond to the traditional furin site (135-
RKRR-138) and the polybasic tract (178-RKRK-181) identified as cleavage sites for
complete activation by furin and CAP1 (16) (Figure S1C). This observation is in agreement
with previous computational analyses reporting preference for intrinsic structural disorder in
cleavage by serine proteases (5).
To elucidate the structural basis for substrate recognition and activation of ENaC by CAP3,
we performed replica exchange DMD simulations (20, 29) of three peptide sequences (Seq1,
2, 3) from rat γ-ENaC (Materials and Methods) to study peptide binding to the active pocket
of furin and CAP3 starting with the unbound state (Figure S2A, B). Using RMSD as the
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clustering criterion, we selected five final structures for each enzyme-substrate combination
(Figure S2C). We found that the maximum RMSD between structures of peptide complexes
with either furin or CAP3 is 1.5 Å. The final substrate-bound configurations of both furin
and CAP3 satisfy the distance constraints imposed during simulations (Materials and
Methods, Figure 1A, C). The peptide-bound configurations also portray the differences in
the size, shape and charge distribution of the active sites of furin and CAP3 (Figure 1B, D).
In our models, the residue at the P1 site of Seq1 is positioned in charge complementary
pockets of both furin and CAP3 as observed in the corresponding crystal structures with
bound inhibitors (Figure 1B, D) (30, 31).
To establish the energetic basis for substrate recognition, we computed the two-dimensional
potential of mean force (2D-PMF) with E (normalized energy) and d (distance in Å between
active site residues and the P1, P1’ sites on the peptide) as the two reaction coordinates. We
have unbiased the constrained replica exchange simulations to obtain an accurate measure of
free energy of peptide binding to a given enzyme (Materials and methods). We observe from
the 2D-PMF contours that Seq1 features low energy basins at a distance of 3–5 Å from the
active site of both CAP3 and furin (Figure 2A, B). Similarly, the polybasic tract consisting
of the alternate furin cleavage site (178-RKRK) presents a low energy basin at a distance of
3–5 Å or less from the active site of both furin and CAP3 suggesting that binding of Seq2 to
either enzyme is energetically favorable (Figure 2C, D; black arrows). Takeuchi et al.
proposed that the lysine residue (K132) upstream of the traditional furin site could be the P4
site of a bona fide consensus cleavage motif (132-KESR) for CAP3 (32). To determine
whether a peptide containing this amino acid sequence is energetically compatible to be in
the vicinity of the active site of CAP3, we performed simulations with Seq3 approaching the
active sites of CAP3 and furin. We observe low energy configurations for Seq3 in the active
site of CAP3 in simulations (Figure 2E, Supplementary video 1). Surprisingly, none of the
configurations from the simulation with Seq3 in presence of furin satisfied the distance
constraints for recognition, suggesting that binding of Seq3 to furin is energetically less
favorable (Figure 2F, Supplementary video 2). Such differences are reflected in the contour
plot for furin and CAP3 with Seq3 where a low energy basin at a distance of 3–5 Å from the
active site of furin is absent while a low energy basin is observed in case of CAP3 (compare
Figure 2E, F). These results indicate that CAP3 is more effective than furin at stimulating
ENaC containing γ-ENaC 132KESR. Our computational results suggest low stringency
sequence requirements for CAP3-mediated cleavage and presence of less ideal furin
substrates in this region of γ-ENaC.
Catalytic activity of matriptase is required for activation of ENaC
To biochemically characterize the sequence requirements of CAP3, we first established that
the catalytic activity of CAP3 is required for activation of ENaC. The motivation for this
study arose from the fact that the catalytic activity of CAP1, a GPI-anchored membrane
serine protease, is not required for its regulation of ENaC (18). We found that co-expression
of CAP3 with ENaC for 24 h robustly increased basal amiloride-sensitive sodium current
(INa), typically in the range of 3–5 fold (Figure 3A). Moreover, unlike the basal INa
generated by ENaC alone, the larger basal INa with CAP3 co-expression was not further
increased by application of trypsin (Figure 3A) or hNE. The decrement of INa sometimes
seen following exposure of CAP3-expressing oocytes to exogenous protease (Figure 3A,
ENaC+CAP3, black bar) reflects run down of the stimulated INa. We observed that CAP3
stimulation of ENaC is inhibited by co-expressed hepatocyte activator inhibitor-1 (HAI-1)
(Figure 3B). HAI-1 is a Kunitz-type serine protease inhibitor identified as the physiologic
cognate inhibitor of CAP3 catalytic activity (33). Western blots of CAP3 in lysates of the
injected oocytes show that CAP3 was robustly expressed in its active form, as indicated by
the expected fragmentation pattern of this self-activating protease (Figure 3C) (34).
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Furthermore, co-expression of HAI-1 with CAP3 prevented cleavage associated with CAP3
activation. Co-expression of HAI-2, a related Kunitz-type inhibitor, also completely
prevented CAP3 stimulation of ENaC (Figure 3D) (35). Finally, CAP3 inactivated by
mutation of S805 of the catlaytic triad had no effect on INa of co-expressed ENaC (Figure
3D) (36). Thus, ENaC co-expressed with CAP3 is fully activated through a mechanism that
requires catalytic activity of CAP3.
CAP3 cleaves γENaC at an alternate site N-terminal to the furin site
We studied the role of γ-ENaC in stimulation by CAP3, by co-expressing the furin site
mutants of α-ENaC with WT β- and γ-ENaC in oocytes. CAP3 robustly activated ENaC
without the furin sites in the α-subunit suggesting predominant cleavage of the γ-subunit
(Figure S3A, B). In γ-ENaC, we specifically examined the importance of the basic P1
residue (R138) in the 135-RKRR tract recognized as the furin site. Co-expressed CAP3
robustly stimulated ENaC containing γ-subunit furin resistant mutant R138K and the CAP2
insenstive furin mutant R138A (Figure S3C, D) (14) indicating that CAP3 activates ENaC
by a mechanism involving cleavage at a site distinct from γ-R138. Although the consensus
sequences for convertases (R/K-X-X-R) and CAPs (R/K-X-X-R/K) overlap, some studies
have reported distinct preferences at individual residue positions (37, 38). Therefore, we
asked if extensive mutagenesis of the 135-RKRR tract in γ-ENaC to 135-QQQQ would
affect the action of CAP3 toward ENaC. Co-expressed CAP3 did not stimulate this mutant
ENaC, even though subsequent trypsin exposure lead to significant stimulation (Figure 4B).
Further mutagenesis revealed that the presence of R135 is sufficient for CAP3-mediated
cleavage of γ-ENaC (Figure S4).
To biochemically characterize CAP3-mediated cleavage of γENaC, we performed Western
blot analysis of biotinylated surface protein pool captured on streptavidin beads (Materials
and Methods). We characterized the HA/V5 double epitope labeled γ-ENaC by the pattern
of anti-V5 (C-terminal tag) and anti-HA (N-terminal tag) staining on Western blot (Figure
4C). In oocytes expressing WT ENaC subunits, V5-tagged γ-ENaC at the cell surface exists
as a mixture of full length (“FL”, ~93 kD band) and furin fragments (“FF”, ~75 kD band)
(Figure 4C, top panel). Under basal conditions, HA-label was found in a complementary
~18 kD band (Figure 4C, lower panel) and in a FL band (not shown). With co-expression of
CAP3, a more rapidly migrating fragment of ~70 kD (“DF”, distal fragment) replaces the FF
band, a result now seen as characteristic of proteolysis of γ-ENaC at a site 20–40 residues
downstream of the furin site (16, 39, 40). The 18 kD anti-HA reactive (N-terminal) fragment
indicates that cleavage at the traditional furin site is not affected. As predicted, mutant γ-
ENaC containing the 135-QQQQ tract shows no FF, either V5- or HA-labeled, when co-
expressed with α- and β-ENaC alone (Figure 4C, lane 4). However, when co-expressed with
CAP3, the proportion of FL V5-labeled γ-135-QQQQ at the cell surface decreases, with a
significant increase in the intensity of the DF fragment (Figure 4C, lane 5). A
complementary N-terminal HA-labeled mutant γ-ENaC fragment of ~23 kD appears at the
surface of CAP3 co-expressing cells (Figure 4C, lower panel, lane 5). These results indicate
that cleavage within the 135–138 furin site is blocked in γ-135-QQQQ while CAP3 induces
cleavage C-terminal to the furin site. In addition, we conclude that cleavage within residues
135–138 is essential for CAP3 stimulation of ENaC.
Based on previous reports and our computational analyses, we hypothesized that K132 could
be part of a bona fide consensus motif (132-KESR) targeted by transmembrane serine
proteases (TSPs) or furin-like convertases (32, 41). To test this hypothesis, we generated γ-
ENaC with 132-HESRQQQ, which associates with WT α- and β-ENaC to produce reduced
INa that responds briskly to hNE (2 µg/ml) or trypsin (20 µg/ml) (Figure S4, black bars).
Although the presence of 132-KESR is evidently not optimal for endogenous convertases,
we reasoned that over-expressed furin might recognize this site. Because the preference of
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furin at the P1 residue is strong for arginine over lysine (42), while CAP3 is reported to
tolerate lysine at P1 (32), we compared the ability of co-expressed human furin and CAP3 to
stimulate the γ-ENaC mutants 135-RQQQ and 135-KQQQ. To simplify interpretation, we
expressed these mutant γ-subunits with WT β-ENaC and with α-ENaC furin site mutant
(Figure 4D). Interestingly, co-expressed human furin partially activated ENaC containing
γ-132-KESRQQQ, to 35% of maximum stimulated INa, albeit less efficiently than CAP3
which led to 60% of maximum stimulated INa (Figure 4D, left panel). Co-expressed furin
did not stimulate ENaC with a lysine at position 135 (Figure 4D, right panel) while CAP3
stimulated this mutant, albeit to a lesser extent than the mutant with R135 preserved. These
results suggest that CAP3, due to its less stringent sequence requirements, can target basic
residues in the 132–138 tract of γ-ENaC that are more resistant to endogenous convertases
and over-expressed furin.
CAP3 cleaves ENaC at multiple sites C-terminal to the furin site
A candidate site for cleavage events responsible for the broadly staining DF (~70 kD)
(Figure 4C) is the tract 178-RKRK, as this polybasic region is required for cleavage of γ-
ENaC by CAP1 (16), and shares the same minimal sequence requirements for cleavage with
CAP3 (43). DMD simulations revealed that CAP3/furin binding at this site is energetically
favorable. Surprisingly, however, γ-ENaC with 178-QQQQ was stimulated by co-expressed
CAP3 to about the same extent as ENaC containing WT γ-subunit (Figure 5A). The CAP3-
stimulated basal current in either WT or mutant channel groups was not further increased by
hNE, indicating that CAP3 attained full proteolytic stimulation of mutant ENaC at the
surface. In addition, the patterns of C-terminal V5-labeled fragments of WT or mutant γ-
ENaC contained in the cell surface pool of each expression group were affected similarly by
co-expressed CAP3, each showing a shift from a mixture of FL or FF to a population
dominated by DFs, consistent with CAP3-induced cleavage at sites downstream from the
furin site (Figure 5A, lower panel). While these results do not refute the fact that 178-RKRK
is a potential cleavage site, the data indicate that other potential cleavage sites exist in the
vicinity of this basic tract.
As mutation of the polybasic tract 178-RKRK has no effect on CAP3-mediated stimulation
or banding pattern of γ-ENaC fragments, we tested the contribution of flanking basic
residues in the region from residues 172 to 202. We investigated the importance of 172R,
185K, 189K and 201K, 202K, individually, and in various combinations with 178-QQQQ.
We observed no significant effects of mutating any single basic residue in this region on
CAP3 cleavage and stimulation of ENaC. However, from a threshold of mutating 6–7 basic
residues, up to 9 basic residues in this region replaced by glutamine, we observed
progressively decreased CAP3-mediated stimulation of INa, staining density of DF, and
resting whole cell Po. Particularly, ENaC containing mutant γ-subunits with eight
glutamines substituted for basic residues within the 172–202 tract (“8Q”) was only partially
stimulated by co-expressed CAP3 (Figure 5B). Western blot analysis of the C-terminal V5-
tagged fragments of 8Q γ-ENaC on the cell surface suggests that in this extensively mutated
channel, CAP3 generates an intermediate fragment (IF) that migrates between FF and DF,
characteristic of WT γ-ENaC (Figure 5B). Thus, CAP3 cleaves ENaC at multiple basic sites
including those that do not conform to the furin consensus sequence requirements. These
results are in agreement with our conclusion that CAP3 has less stringent sequence
requirements for cleavage than furin. It is likely that the local structure of the protein is
altered upon extensive mutagenesis, thereby hampering cleavage. Assuming that the
structure of ENaC is intact, our results suggest that CAP3 cleaves γ-ENaC at multiple sites
C-terminal to the furin site resulting in robust channel activation.
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Here, we report the energetic, structural and sequence requirements for cleavage of ENaC by
CAP3 and furin. While we focus our attention on activation of ENaC by proteases, the
results of our computational analyses are broadly applicable to catalysis by serine proteases.
Limited endoproteolysis of ENaC is a complex mechanism for regulating Na+ absorption by
epithelia. Numerous proteases that stimulate ENaC have been identified, alongside
endogenous protease inhibitors that oppose this effect (12, 13). Thus, ENaC may be
controlled in a tissue specific manner by the complement of endogenous proteases and anti-
proteinases expressed in a given cell type. We experimentally characterized the effects of
CAP3 co-expression on proteolysis and stimulation of ENaC in Xenopus oocytes. We
identified two regions of γ-ENaC susceptible to direct cleavage by CAP3. Cleavage after
any of several basic residues within each region is necessary and sufficient for full
stimulation of ENaC. These observations support three main conclusions. First, cleavage of
the γ-subunit alone accounts for CAP3 stimulation of ENaC. Second, though limited in
extent, the specificity of γ-ENaC cleavage is not based on stringent docking of extended
segments of γ-ENaC within the active site in CAP3. Instead, multiple basic residues
comprising the γ-ENaC furin site, along with those including and flanking 178-RKRK are
exposed for proteolysis. Finally, CAP3 alone can achieve full proteolytic stimulation of
ENaC.
Structural studies of ENaC are set back due to the unavailability of a complete atomistic
structure of the heteromultimer. Recently, different ENaC subunits were threaded onto the
structure of a homologous acid-sensing ion channel (ASIC1) (44, 45). In the sequence
alignment used for model building, the region in γ-ENaC containing the putative cleavage
sites for CAP3 and furin was designated the “hypervariable region” (44). Consequently, the
structural features of this region are unavailable despite the modeling efforts. The
observation that the protease cleavage sites in ENaC are intrinsically disordered is in line
with the proposed structural requirement for serine protease activity (5, 6). To study the
energetic basis for substrate recognition by CAP3 and furin, we performed DMD
simulations of both enzymes with different candidate peptides. Although crystal structures
of matriptase/CAP3 (PDB: 1EAW) and furin (PDB: 1P8J) with bound inhibitors are
available for this effort (30, 31, 46), we reasoned that the static orientation of an inhibitor in
the catalytic pocket does not effectively capture the dynamics of enzyme-substrate
complexes. Therefore, we resorted to DMD simulations and we observed from the low
energy configurations that a charge complementary pocket in both furin and CAP3 mediates
critical enzyme-peptide interactions (Figure 1B, D). While these simulations are not
intended to model the hydrolysis reaction carried out by either enzyme, they provide insight
into the binding properties of a given enzyme-peptide combination. Given that substrate
recognition is the first step in hydrolysis, we consider a peptide that can reach the vicinity of
the enzyme (3–5 Å) as a potential substrate for cleavage. By maintaining most of the
enzyme static during simulations, we assume that furin and matriptase do not undergo
significant conformational changes during peptide recognition. Furthermore, by using an
implicit solvent model (EEF1) for treating solvent interactions, we disregard specific water-
mediated hydrogen bond formation involved in hydrolysis. Therefore, our simulation studies
are only aimed at determining whether a given peptide is energetically suitable for
presenting itself in the proximity (within 3–5 Å) of the active site of furin or matriptase, and
not to quantify the rate of hydrolysis of a given peptide by a protease. PMF analysis with
Seq1 features low energy basins at the active sites of both furin and CAP3 suggesting that
Seq1 can be a substrate for both enzymes. Interestingly, analogous computational study of
Seq3 indicates that 132KESR can be a substrate for CAP3 but not for furin. This result is
consistent with our observation that CAP3 cleaves and stimulates ENaC effectively when
132KESR are the only potentially susceptible residues available near the furin site, whereas
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exogenous furin is much less effective at stimulating ENaC in this context (Figure 3D).
These computational analyses of WT sequences, with our functional and biochemical
analyses of WT and mutant γ-ENaC clearly indicate that the γ-ENaC sequence 132-
KESRKRR is highly susceptible to cleavage by CAP3.
CAP3, unlike furin in this study, or CAP2 in our previous work (14), appears to cleave γ-
ENaC after several basic residues within 132-KESRKRR, including 135R, 136K and 138R.
Such greater susceptibility of γ-ENaC to cleavage may reflect CAP3’s low substrate
stringency coupled with favorable substrate access due to local structural disorder. 2D-PMF
analyses of all peptide-catalytic site combinations considered in this study broadly support
this notion. Energy minima at 3–5 Å indicate close contact between peptide and catalytic
site required for proteolysis (Figure 2), whereas low energy basins beyond 5 Å are
suggestive of electrostatic attraction between the net positively charged peptides and the
negatively charged surface loops of the enzyme. The absence of a low energy basin at a
distance of 3–5 Å from the active site reflects the fact that Seq3 is a less suitable substrate
for furin than CAP3 (Figure 2E, F). Seq1 and Seq2 feature energy minima at 3–5 Å from the
active site of both CAP3 and furin (compare Figure 2A, B and C, D). Low energy basins
corresponding to interaction between the peptide and the surface loops of the enzyme are
observed beyond 5 Å for all peptides in simulations. However, only Seq1 and Seq2 are
energetically compatible to be in the proximity of the active of CAP3 and furin, as
evidenced from the PMF analysis (Figure 2A–D). PMF analysis indicates that it is favorable
for Seq3 to be in the vicinity of CAP3, but not furin. In light of these observations, we
propose an “anglerfish” mechanism analogous to the characteristic mode of predation by the
anglerfish where the fish represents the enzyme, with its illicium being the surface loops that
capture the peptide to be cleaved and proteolysis being the eventual irreversible event
(Figure 6). The realization of this mechanism is confined by the assumption that proteolysis
is guaranteed if a peptide is energetically compatible to be in the vicinity (3–5 Å) of the
active site of a hydrolytic enzyme.
Our examination of CAP3 activity suggests that several different events underlie stimulation
of ENaC. Mutation analysis suggests that 132K participates in a sequence (132-KESR)
predicted to be optimal for cleavage by CAP3 (32). Residual cleavage and stimulation of
ENaC containing γ-135-RQQQ requires the intact sequence 132-KESR. Mutagenesis of the
furin sites in α-ENaC has no effect on CAP3 stimulation of ENaC, even though CAP3
converts all FL WT α-ENaC to fragments expected from cleavage at the two furin sites,
similar to our previous study with CAP2 (14). The stimulation of ENaC by CAP1 was also
linked by mutagenesis to γ-ENaC (16). Complete proteolytic stimulation of ENaC by
soluble serine proteases, including trypsin, hNE and plasmin is also exerted by cleavage of
the γ-subunit (40, 47, 48). Thus, our results demonstrating that CAP3-mediated stimulation
of ENaC can be blocked by mutations in γ-ENaC add to a growing body of data indicating
that γ-ENaC plays a central role in the proteolytic regulation of ENaC.
Based on our results, cleavage of γ-ENaC mediated by CAP3 occurs in two regions: the first
is discretely defined by the furin site and the second includes basic residues centered on and
surrounding the 178-RKRK tract. CAP3’s low stringency requirements for cleavage are
consistent with its cleavage of γ-ENaC at multiple basic residues downstream of the furin
cleavage site. Our results provide a compelling hypothesis that recognition and/or cleavage
of γ-ENaC by proteases is substantially determined by accessibility of key sites rather than
solely by a stringent structural requirement. The ability of certain proteases to activate ENaC
has been linked to a specific residue or tract within 172–202 (16, 40, 47, 48). Based on such
work for prostasin (CAP1), the initial expectation was that CAP3 would cleave at the 178-
RKRK tract. However, when 178-RKRK is unavailable, both CAP2 and CAP3 readily
cleave at multiple basic residues in the region 172–202. This phenomenon is consistent with
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the concept that this region is highly accessible to proteases due to intrinsic structural
disorder. The low stringency of CAP3 explains why we could not identify a single residue or
short tract that can be mutated to block CAP3 stimulation of ENaC. We expect the
accessibility of either region to increase with time and extent of proteolysis, leading to
further cleavage and consequent activation by relatively non-specific proteases.
Our results indicate that CAP3 potently stimulates ENaC in an in vitro setting, which is
dependent on direct catalytic attack of the protease on extracellular segments of γ-ENaC. It
has been suggested that CAP3 completes its auto-activation at the cell surface (49, 50). As a
step towards understanding the colocalization of ENaC and CAP3 in vivo, we performed
immunofluorescence microscopy to confirm that matriptase localizes to the subapical pools
near the plasma membrane of human bronchial epithelial (HBE) cells derived from different
individuals (Figure S5). ENaC can be detected in apical and subapical compartments of
HBE cultures and is processed by limited cleavage in these cells (51, 52). Thus, it appears
highly likely that ENaC is cleaved by matriptase in HBE cells. Additional work is needed to
confirm that ENaC and active CAP3 occupy positions at the cell surface that enable ENaC
cleavage, but our results clearly imply that CAP3 is capable of activating ENaC independent
of furinlike convertases. CAP3 also activates CAP1 (53), which stimulates ENaC regardless
of its catalytic activity (54). These and other recent observations suggest a possibility for a
cascade of interactions at the cell surface involving CAP3 and other proteases like CAP1,
exercising dynamic control over proteolytic regulation of ENaC (55).
We conclude that CAP3, a MAP, can independently activate ENaC without contributions
from furinlike convertases or soluble proteases, without a requirement for specific structural
motifs for recognition and/or cleavage. Our computational analyses give rise to a potentially
generic “anglerfish” mechanism applicable broadly to serine protease mediated recognition
and cleavage.
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Figure 1. Structural models of peptides from γ-ENaC bound to furin and CAP3
A) Final docked configuration of peptide Seq1 in the active pocket of CAP3. Inset shows the
distances between amine of the P1’ site from the NE2 of active site histidine and that of the
carbonyl oxygen of the P1 site from the OG of active site serine. B) Electrostatic surface
representation of CAP3 with the side chains of residues in peptide Seq1 shown as sticks.
The guanidium group of the arginine at the P1 site docks into a negatively charged groove in
the enzyme. C) Final docked configuration of the peptide Seq1 in the active pocket of furin.
Inset shows the distances between amine of the P1’ site from the NE2 of the active site
histidine and that of the carbonyl oxygen of the P1 site from the OG site of active site serine.
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D) Electrostatic surface representation of furin with the side chains of residues in peptide
Seq1 shown as sticks. The guanidium group of arginine at P1 site docks into a negatively
charged groove in the enzyme.
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Figure 2. Energetic basis for peptide binding to furin and CAP3
2D-PMF with normalized energy of enzyme-substrate complex and distance between the
active site and respective peptides as reaction coordinates. The color on the 2D-PMF plot is
indicative of the free energy of peptide binding to the enzyme. Darker the color, lower the
free energy in kcal/mol. The peptide is colored red and the enzyme is colored gray in the
accompanying models representing the minimum energy configurations for the
corresponding enzyme-peptide combinations. A, B) 2D-PMF of Seq1 binding to CAP3 and
furin respectively. C, D) 2D-PMF of Seq3 binding to CAP3 and furin respectively. E, F)
2D-PMF of Seq3 binding to CAP3 (video 1) and furin (video 2) respectively. Seq3 is
energetically incompatible to be in the vicinity of the active site of furin while it reaches the
active site of CAP3.
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Figure 3. Catalytic activity of matriptase/CAP3 is required for stimulation of ENaC
A, B) Coexpression of the Kunitz domain containing inhibitor, HAI-1 blocks stimulation of
ENaC. Oocytes were co-injected with 0.3 cRNA of α, β and γ-ENaC alone (Panel A), or in
combination with 1 ng cRNA of HAI-1 (Panel B). After 24 h incubation, amiloride-sensitive
current (INa) was recorded before (gray bars) and following (black bars) 5 min exposure to 2
µg/ml trypsin. C) Expression and autocleavage of matriptase/CAP3, and effect of HAI-1.
Oocyte lysates from (A) and (B). were studied by Western blotting using anti-CAP3
antibody. D) CAP3 stimulation of ENaC was blocked by co-expressed HAI-2 or by
mutating serine 805 of the catalytic triad. Experiments were repeated on 2–4 batches of
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oocytes, with a total of 12–26 oocytes per condition. *Trypsin stimulated INa different from
basal INa. **Basal INa different from ENaC alone. ANOVA, p < 0.05.
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Figure 4. CAP3 mediates neither activation nor cleavage of γ-135QQQQ ENaC
A) WT ENaC was expressed alone or with CAP3. INa was recorded 24 hr after cRNA
injection, before (gray bars) and after (black bars) a 5 min trypsin exposure. B) ENaC
containing the mutant γ135QQQQ was expressed alone or with CAP3. INa was recorded as in
A. C) ENaC made of WT subunits or containing the mutant γ-135QQQQ were expressed
alone or with CAP3. After 24 h, uninjected (U.I.) oocytes and oocytes from each treatment
group were surface biotinylated and the surface protein pool was captured on streptavidin
beads. Full length and fragments of HA/V5 γ-ENaC were recognized by blotting for V5 (C-
terminal epitope) or HA (N-terminal epitope). FL = full length; FF = furin fragment; DF
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=distal fragment. D) Oocytes were injected with αFM,β and either γ135RQQQ (left) or
γ135KQQQ (right). Each of these ENaC combinations was expressed alone or co-expressed
with furin or CAP3, and studied after 24 h. Basal INa was recorded before and following 5
min exposure to 2 µg/ml hNE. Basal INa as raw current (left ordinate) or as a percent of
maximum INa following elastase (right ordinate) is shown. Mean values were compared by
ANOVA and Tukey’s test applied. a = different from mutant γ alone, b = different from
mutant γ + furin, p < 0.01.
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Figure 5. The basic tract 178-RKRK in γ-ENaC is not essential for CAP3 stimulation of INa
A) WT HA/V5-γ-ENaC or HA/V5-γ-RKRK(178–181)QQQQ cRNA was co-injected with
WT α- and β-ENaC cRNA (0.3 ng/subunit). Half of each group was also injected with 1 ng
cRNA for CAP3. INa was recorded after 24 h, before and following 5 min of exposure to 2
µg/ml hNE (upper panel, N = 10–12 oocytes per condition from two batches). 30–60 oocytes
per condition were surface biotinylated, as described elsewhere. WT and mutant γ-ENaC
fragments present in the cell surface pool were analyzed by Western blot (lower panel). B)
WT α- and β-ENaC subunits were expressed for 24 h with WT or mutant (8Q) HA/V5 γ-
ENaC, with or without CAP3 (see text for description of mutant 8Q). INa was recorded
before and following 5 min exposure to 20 µg/ml trypsin (a = different from WT basal; b =
different from 8Q basal, p < 0.01) Surface biotinylated proteins from the same injection
groups were analyzed by anti-V5 Western blotting are shown in lower panel. FL = Full
Length; FF + Furin Fragment; DF = Distal Fragment; IF = Intermediate Fragment.
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Figure 6. “Anglerfish” mechanism of peptide recognition and cleavage by MAPs
A two-step mechanism depicting the importance of surface loops in proteolysis by MAPs.
The incoming peptide interacts with the surface loops and is ultimately delivered to the
active site resulting in irreversible cleavage. 2D-PMF analyses reveal the energetic basis for
this mechanism.
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